Summit Therapeutics (SMMT) Short-Term Debt repayments (2018 - 2020)
Historic Short-Term Debt repayments for Summit Therapeutics (SMMT) over the last 3 years, with Q1 2020 value amounting to -$51000.0.
- Summit Therapeutics' Short-Term Debt repayments fell 14896.79% to -$51000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was -$165177.7, marking a year-over-year increase of 6222.69%. This contributed to the annual value of -$435000.0 for FY2019, which is N/A changed from last year.
- According to the latest figures from Q1 2020, Summit Therapeutics' Short-Term Debt repayments is -$51000.0, which was down 14896.79% from -$113143.8 recorded in Q4 2019.
- Over the past 5 years, Summit Therapeutics' Short-Term Debt repayments peaked at $104149.8 during Q1 2019, and registered a low of -$318511.4 during Q3 2018.
- Moreover, its 3-year median value for Short-Term Debt repayments was -$109163.8 (2018), whereas its average is -$100238.9.
- The largest annual percentage gain for Summit Therapeutics' Short-Term Debt repayments in the last 5 years was 14896.79% (2020), contrasted with its biggest fall of 14896.79% (2020).
- Summit Therapeutics' Short-Term Debt repayments (Quarter) stood at -$105183.7 in 2018, then dropped by 7.57% to -$113143.8 in 2019, then soared by 54.92% to -$51000.0 in 2020.
- Its Short-Term Debt repayments was -$51000.0 in Q1 2020, compared to -$113143.8 in Q4 2019 and $104149.8 in Q1 2019.